Clinical Trials in New York

Showing 21821-21840 of 22,668 trials

Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema

NCT00944944

The purpose of this study is to evaluate if the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) truly detects symptoms or signs of lower extremity lymphedema in patients with diagnosed lower extremity lymphedema. Lymphedema is a chronic condition in which fluid accumulates in the tissues of the body. Many cancer survivors are living with discomfort and changes in their activities due to limb swelling following cancer treatment. If the GCLQ is able to do detect signs and symptoms of lymphedema, the investigators hope to use it as a tool in the clinical care setting to help identify women at risk for or with lymphedema. In the future, this could improve clinical care through the use of a more simple and feasible way to identify lower extremity lymphedema than measuring limbs.

Ovarian CancerUterine CancerVaginal Cancer+1 more

Memorial Sloan Kettering Cancer Center58 participantsStarted Jul 2009

New York, New York, United States

COMPLETEDPhase 1< 1 mile

Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes Mellitus (T1DM)

NCT00073255

To assess the tolerability and safety of hOKT3g1 (Ala-Ala) after a 12-day dosing regimen administered via intravenous infusion. To assess the pharmacokinetics of hOKT3g1 (Ala-Ala).

Diabetes Mellitus, Insulin-Dependent

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)12 participantsStarted Jun 2003

New York, New York, United States

Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema

Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes Mellitus (T1DM)

Find Trials by Condition in New York

The Effect of Vitamin D and Calcium on Bone in Pediatric HIV

Prevention of Type 2 Diabetes Mellitus in Children

Combination Iron Chelation Therapy

A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose

Minimally Invasive Surgical Therapy for BPH

Quality Of Life in Patients With Malignant Biliary Obstruction

Treatment of Bulimia Nervosa in a Primary Care Setting

Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety

Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC

A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity

Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection

Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*

Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis

Safety and Efficacy Evaluation of Erbium Treatment

Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis